Author ORCID Identifier
Date of Graduation
Doctor of Philosophy (PhD)
Richard Bouchard, PhD
David Fuentes, PhD
Christine Peterson, PhD
Konstantin Sokolov, PhD
R. Jason Stafford, PhD
While conventional diagnostic imaging modalities provide anatomical information to clinicians, these techniques are not sensitive to critical physiological processes. In order to properly classify cancer, it is necessary to investigate noninvasive methods which can provide insight into these processes, allowing clinicians to determine personalized therapeutic options. Therefore, molecular imaging is focused on visualization and characterization of biomarkers within the tumor microenvironment (TME), which can then be combined with the anatomical information provided from diagnostic imaging.
Two such biomarkers of interest are blood oxygen saturation (SO2) and cell receptor expression. SO2 is a measure of the fraction of hemoglobin which is bound to oxygen, which has been shown to correlate to tumor progression. Additionally, several cancer subtypes have been shown to overexpress specific cell receptors (e.g., EGFR). Therefore, cell receptor expression has emerged as a biomarker which can help the physician to identify potential beneficial treatment options. While molecular imaging methods are being explored in order to assess these two biomarkers, current methods suffer from limitations such as poor spatio-temporal resolution and poor depth penetration. To overcome these limitations, ultrasound (US)-mediated imaging techniques have been investigated to characterize these molecular imaging biomarkers.
The objective of this work is to develop and validate US-mediated techniques to investigate the TME biomarkers of SO2 and cell receptor expression. In this work, photoacoustic (PA) imaging methods were developed along with optical fluence modeling techniques in order to improve accuracy and precision of SO2 estimates. SO2 estimation accuracy was shown to improve from 16.8% error to 3.2% error with a precision of 2.3% in tissue-mimicking phantoms, while in vivo estimation of SO2 in a rat artery (i.e., expected value >95%) increased from 92.9±2.9% to 95.5±1.2%.
Additionally, a high-frequency US-mediated imaging platform was developed to image and activate phase-changing perfluorocarbon nanodroplet contrast agents (PNCAs). Using this imaging platform, PNCAs were activated and imaged to determine PNCA enhancement. Optimal PNCA particles generated a median signal enhancement of 6.2 in a phantom environment after US activation, while a pilot in vivo study showed significant US-mediated PNCA activation of two separate intra-muscular injections in the hind limb.
Ultrasound-mediated Imaging, Quantitative Imaging, Photoacoustic Imaging, Activatable Perfluorocarbon Nanodroplet Contrast Agents
Available for download on Friday, October 22, 2021